Table Of Content
Contents
- Executive Summary
- AI for Drug Discovery
- AI for Drug Discovery Product Overview
- Market Definition
- Segmentation
- Assumptions and Acronyms
- Research Methodology
- Research Objectives
- Primary Research
- Secondary Research
- Forecast Model
- Market Size Estimation
- Average Pricing Analysis
- Market Dynamics
- Growth Drivers
- Restraints
- Opportunity
- Trends
- Recent Development, Policies & Regulatory Landscape
- Risk Analysis
- Demand Risk Analysis
- Supply Risk Analysis
- AI for Drug Discovery Industry Analysis
- Porters Five Forces
- Threat of New Entrants
- Bargaining Power of Suppliers
- Threat of Substitutes
- Rivalry
- PEST Analysis
- Political
- Economic
- Social
- Technological
- Global AI for Drug Discovery Market
- Market Size & forecast, 2019A-2030F
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Global AI for Drug Discovery: Market Segmentation
- By Regions
- North America: (U.S. and Canada)
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa)
- By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- By Offering: Market Share (2020-2030F)
- Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- By Drug Type: Market Share (2020-2030F)
- Small Molecule, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Large Molecules, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4. By Technology: Market Share (2020-2030F)
10.4.1. Machine Learning, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.4.2. Other Technologies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5. By Application: Market Share (2020-2030F)
10.5.1. Immuno-Oncology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5.2. Neurodegenerative Diseases, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5.3. Cardiovascular Disease, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5.4. Metabolic Diseases, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.5.5. Other Applications, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6. By End-users: Market Share (2020-2030F)
10.6.1. Pharmaceutical & Biotechnology Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.2. Contract Research Organizations, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.3. Research Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.6.4. Academic & Government Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
- Company Profile
- Microsoft
- Company Overview
- Company Total Revenue (Financials)
- Market Potential
- Global Presence
- Key Performance Indicators
- SWOT Analysis
- Product Launch
- NVIDIA Corporation
- IBM Corporation
- Atomwise, Inc
- Insilico Medicine
- BenevolentAI Ltd
- Exscientia
- Cyclica Inc
- Numerate
- NuMedii, Inc
- DEEP GENOMICS
- Cloud Pharmaceuticals, Inc
Consultant Recommendation
The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Select License Type
.png){kind=icon}
